349 related articles for article (PubMed ID: 34801748)
1. Advances in mRNA and other vaccines against MERS-CoV.
Tai W; Zhang X; Yang Y; Zhu J; Du L
Transl Res; 2022 Apr; 242():20-37. PubMed ID: 34801748
[TBL] [Abstract][Full Text] [Related]
2. Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies.
Choi JA; Kim JO
J Microbiol; 2022 Mar; 60(3):238-246. PubMed ID: 35089585
[TBL] [Abstract][Full Text] [Related]
3. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
[TBL] [Abstract][Full Text] [Related]
4. Development of virus-like particles-based vaccines against coronaviruses.
Yong CY; Liew WPP; Ong HK; Poh CL
Biotechnol Prog; 2022 Nov; 38(6):e3292. PubMed ID: 35932092
[TBL] [Abstract][Full Text] [Related]
5. Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus.
Hashemzadeh A; Avan A; Ferns GA; Khazaei M
Vaccine; 2020 Aug; 38(36):5742-5746. PubMed ID: 32684497
[TBL] [Abstract][Full Text] [Related]
6. Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species.
Peng L; Fang Z; Renauer PA; McNamara A; Park JJ; Lin Q; Zhou X; Dong MB; Zhu B; Zhao H; Wilen CB; Chen S
Cell Rep; 2022 Aug; 40(5):111160. PubMed ID: 35921835
[TBL] [Abstract][Full Text] [Related]
7. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
[TBL] [Abstract][Full Text] [Related]
8. Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells.
Wu YH; Yeh IJ; Phan NN; Yen MC; Hung JH; Chiao CC; Chen CF; Sun Z; Hsu HP; Wang CY; Lai MD
J Microbiol Immunol Infect; 2021 Oct; 54(5):845-857. PubMed ID: 34176764
[TBL] [Abstract][Full Text] [Related]
9. Genetically Engineered Live-Attenuated Middle East Respiratory Syndrome Coronavirus Viruses Confer Full Protection against Lethal Infection.
Gutiérrez-Álvarez J; Honrubia JM; Fernández-Delgado R; Wang L; Castaño-Rodríguez C; Zúñiga S; Sola I; Enjuanes L
mBio; 2021 Mar; 12(2):. PubMed ID: 33653888
[TBL] [Abstract][Full Text] [Related]
10. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection.
Costanzo M; De Giglio MAR; Roviello GN
Curr Med Chem; 2022; 29(1):4-18. PubMed ID: 34355678
[TBL] [Abstract][Full Text] [Related]
11. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
[TBL] [Abstract][Full Text] [Related]
12. An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies.
Zhang N; Shang J; Li C; Zhou K; Du L
Expert Rev Vaccines; 2020 Sep; 19(9):817-829. PubMed ID: 32842811
[TBL] [Abstract][Full Text] [Related]
13. Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus.
Jung SY; Kang KW; Lee EY; Seo DW; Kim HL; Kim H; Kwon T; Park HL; Kim H; Lee SM; Nam JH
Vaccine; 2018 Jun; 36(24):3468-3476. PubMed ID: 29739720
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress.
Kovalenko A; Ryabchevskaya E; Evtushenko E; Nikitin N; Karpova O
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675218
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
16. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
[TBL] [Abstract][Full Text] [Related]
17. Prospects for a MERS-CoV spike vaccine.
Zhou Y; Jiang S; Du L
Expert Rev Vaccines; 2018 Aug; 17(8):677-686. PubMed ID: 30058403
[TBL] [Abstract][Full Text] [Related]
18. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.
Agnihothram S; Yount BL; Donaldson EF; Huynh J; Menachery VD; Gralinski LE; Graham RL; Becker MM; Tomar S; Scobey TD; Osswald HL; Whitmore A; Gopal R; Ghosh AK; Mesecar A; Zambon M; Heise M; Denison MR; Baric RS
mBio; 2014 Mar; 5(2):e00047-14. PubMed ID: 24667706
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: Coronavirus Vaccine Development Updates.
Zhao J; Zhao S; Ou J; Zhang J; Lan W; Guan W; Wu X; Yan Y; Zhao W; Wu J; Chodosh J; Zhang Q
Front Immunol; 2020; 11():602256. PubMed ID: 33424848
[TBL] [Abstract][Full Text] [Related]
20. Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review.
Choi J; Kim MG; Oh YK; Kim YB
Expert Opin Ther Pat; 2017 Jun; 27(6):721-731. PubMed ID: 28121202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]